AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $666,000 | +27.3% | 70,872 | +3.7% | 0.00% | 0.0% |
| Q2 2020 | $523,000 | +23.3% | 68,372 | -0.3% | 0.00% | 0.0% |
| Q1 2020 | $424,000 | -52.5% | 68,600 | -6.4% | 0.00% | 0.0% |
| Q4 2019 | $892,000 | -3.9% | 73,300 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $928,000 | +29.2% | 80,327 | +11.8% | 0.00% | 0.0% |
| Q2 2019 | $718,000 | -32.5% | 71,853 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $1,064,000 | -19.5% | 82,584 | -5.1% | 0.00% | -50.0% |
| Q4 2018 | $1,321,000 | -23.5% | 86,987 | +0.8% | 0.00% | 0.0% |
| Q3 2018 | $1,726,000 | -1.9% | 86,297 | -4.4% | 0.00% | 0.0% |
| Q2 2018 | $1,760,000 | -9.3% | 90,252 | -6.3% | 0.00% | -33.3% |
| Q1 2018 | $1,941,000 | +73.9% | 96,339 | +14.4% | 0.00% | +50.0% |
| Q4 2017 | $1,116,000 | -28.2% | 84,241 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,554,000 | +2.0% | 84,241 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $1,524,000 | -16.6% | 82,800 | +2.2% | 0.00% | -33.3% |
| Q1 2017 | $1,827,000 | -37.9% | 81,000 | -4.1% | 0.00% | -40.0% |
| Q4 2016 | $2,941,000 | +35.1% | 84,500 | -4.8% | 0.01% | +25.0% |
| Q3 2016 | $2,177,000 | -4.3% | 88,800 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $2,275,000 | -0.9% | 95,100 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $2,296,000 | -26.9% | 98,100 | -5.7% | 0.00% | -20.0% |
| Q4 2015 | $3,140,000 | -47.7% | 104,000 | -31.1% | 0.01% | -50.0% |
| Q3 2015 | $5,999,000 | -41.0% | 151,000 | +2.6% | 0.01% | -33.3% |
| Q2 2015 | $10,166,000 | +109.4% | 147,200 | +34.4% | 0.02% | +114.3% |
| Q1 2015 | $4,855,000 | 0.0% | 109,500 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $4,855,000 | +92.6% | 109,500 | +38.6% | 0.01% | +133.3% |
| Q3 2014 | $2,521,000 | +54.0% | 79,000 | 0.0% | 0.00% | +50.0% |
| Q2 2014 | $1,637,000 | +15.1% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,422,000 | -24.8% | 79,000 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $1,890,000 | +10.1% | 79,000 | -1.2% | 0.00% | 0.0% |
| Q3 2013 | $1,717,000 | -10.0% | 79,954 | -6.8% | 0.00% | -25.0% |
| Q2 2013 | $1,908,000 | – | 85,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |